Menu
Recruiting NCT07464379

Basic and Clinical Research of Pregnancy-Induced Hypertension

Observational Pregnancy-induced Hypertension

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: no Intervention.
Who it may be relevant to
Registry conditions: Pregnancy-induced Hypertension. Basic parameters: 20 years — 50 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Collect Blood Pressure, Blood, Amniotic Fluid, Placenta and Other Samples From Normal Pregnant Women, Patients With Pregnancy-induced Hypertension and Those Who Have Experienced Miscarriage, and Conduct Tests on Them.

Overview

Collect blood pressure, blood, amniotic fluid, placenta and other samples from normal pregnant women, patients with pregnancy-induced hypertension and those who have experienced miscarriage, and conduct tests on them.

Interventions

  • Other no Intervention
    observation

Primary outcome measures

  • PIH [Time frame: Early pregnancy:Weeks 1 to 12 (the first to third months of pregnancy) ;mid-pregnancy:Weeks 13 to 27 (the 4th to 6th month of pregnancy) ;post-delivery period:Weeks 28 to 40 (the 7th to 9th months of pregnancy);the day of delivery。]
Secondary outcome measures (3)
  • PIH [Time frame: delivery]
  • PIH [Time frame: delivery]
  • PIH [Time frame: delivery]

Eligibility criteria

Inclusion criteria

\- Healthy pregnant women, patients with miscarriage, etc.

Exclusion criteria

  • Heart disease, infections, etc. in pregnant women Uncooperative patients

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

China · 1 center
  • The Second Affiliated Hospital of Wenzhou Medical University — Wenzhou

Identifiers

NCT: NCT07464379 · SAHoWMU-CR2025-03-134

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗